Immatics at ASGCT’s pre-meeting CAR T and Immune Effector Cell Therapies Workshop (May 11)

| News, USA

Join us on May 11 for the CAR T and Immune Effector Cell Therapies Workshop to take place virtually right before the American Society of Gene and Cell Therapy 23rd Annual Meeting!

E-meet Amir Alpert then and there and learn more about our TCR-based cancer immunotherapies.

Monday, May 11, 9.40am – 10am EST (2.40pm GMT / 3.40pm CET)

TCR-Based Cancer Immunotherapies to Novel pMHC Targets

  • Introduction to Immatics‘ target discovery engine XPRESIDENT® and next-generation technology platform XCEPTORTM
  • Overview of how thus characterized and optimized TCR candidates are developed towards adoptive cell therapy applications such as Immatics’ phase 1/2 ACTengine® trials

Speaker: Amir Alpert, Assoc. Director Immunology


We are looking forward to virtually meeting you! 

Learn more about the ASGCT and it’s CAR T and Immune Effector Cell Therapies Workshop here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.